Home › Funds › DV EQUITIES, LLC › DMRA
DV EQUITIES, LLC position in DMRA
DAMORA THERAPEUTICS INC COM SHS · Health Care
DV EQUITIES, LLC reported holding 130,000 shares of DMRA (DAMORA THERAPEUTICS INC COM SHS) in its Q2 2026 13F filing — a position valued at US$3.4M, representing 0.49% of its reported portfolio and ranking #41 among its reported holdings. DV EQUITIES, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DV EQUITIES, LLC's DMRA position evolved
DV EQUITIES, LLC first disclosed a stake in DMRA in Q2 2026 at 130,000 shares (US$3.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 130.00K | $3.38M | New |
About DMRA and 13F data
DMRA (DAMORA THERAPEUTICS INC COM SHS) is a Health Care company. 105 other funds we track also report a position in DMRA — the largest reported positions include Fairmount Funds Management LLC (US$226.6M), Avoro Capital Advisors LLC (US$98.4M), Venrock Adviser, LLC (US$93.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DMRA
- Fairmount Funds Management LLC 8.71M sh · $226.63M · Q2 2026
- Avoro Capital Advisors LLC 3.78M sh · $98.40M · Q2 2026
- Venrock Adviser, LLC 3.60M sh · $93.73M · Q2 2026
- FCPM III SERVICES B.V. 2.44M sh · $63.49M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 2.40M sh · $62.42M · Q2 2026
- Remedium Capital Partners, LLC 2.05M sh · $53.20M · Q2 2026
- Commodore Capital LP 1.94M sh · $50.43M · Q2 2026
- BRAIDWELL LP 1.62M sh · $42.15M · Q2 2026
- Bellevue Group AG 1.62M sh · $42.11M · Q2 2026
- a16z Capital Management, L.L.C. 1.24M sh · $32.15M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.22M sh · $31.81M · Q2 2026
- Cormorant Asset Management, LP 1.00M sh · $26.01M · Q2 2026
More on DV EQUITIES, LLC
FAQ
How long has DV EQUITIES, LLC held DMRA?
DV EQUITIES, LLC has disclosed DMRA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is DV EQUITIES, LLC's current position in DMRA?
As of Q2 2026, DV EQUITIES, LLC holds 130.00K shares of DMRA (DAMORA THERAPEUTICS INC COM SHS), valued at $3.38M, representing 0.49% of its reported portfolio and ranking #41.
Has DV EQUITIES, LLC been buying or selling DMRA?
In the latest 13F filing (Q2 2026), DV EQUITIES, LLC newly opened its position in DMRA.
Which other funds hold DMRA?
Other major institutional holders of DMRA include Fairmount Funds Management LLC, Avoro Capital Advisors LLC, Venrock Adviser, LLC, among 105 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.